From reader El: ~~~~~~~~~~~~~~~~~ As usual, I admire your clear thinking on many subjects. I offer this article for your perusal. http://colloidalsilversecrets.blogspot.com/2014/08/colloidal-silver-and-ebola-hysteria.html [Also see: http://thesilveredge.com/study-defense-threat-reduction-agency-silver-nanoparticles-neutralize-hemorrhagic-fever-viruses.shtml -MrF] As I have personally experienced, colloidal silver does not seem to kill viruses, yet, if I use it with a virus-killing agent and/or frequency, the results are much better than not using it. According to this research from the DOD (!), colloidal silver can stop the virus from replicating, but does not kill it per se. Blessings, El ~~~~~~~~~~~~~~~~~ MrFusion replies: That is interesting. Here is the direct link to a PDF which is mentioned in the above linked articles: http://thesilveredge.com/pdf/defense-threat-reduction-agency-silver-nanoparticles-neutralize-hemorrhagic-fever-viruses.pdf It is a slide presentation apparently from scintific briefing, but unfortunately there is no transcript of the presumed oral presentation of the briefing. The briefing appears to address activity in vitro but not in vivo. It seems to say that the nanosilver can prevent these types of hemorrhagic viruses from replicating inside the cell, in experiments in vitro. Unfortunately very high concentrations of nanosilver on the order of 50-100 ppm seem to be required, higher even than in commercially available nanosilver preparations, let alone what can be achieved in animals. Extremely high concentrations of nanosilver would have to be infused intravenously to achieve such levels in the bloodstream in vivo. Nevertheless this is an interesting finding, and giving an Ebola patient colloidal silver couldn’t hurt, along with other therapy, such as the one I would try, high-dose i.v. ascorbate (acid-neutralized Vitamin C). The presentation does not address whether nanosilver is active against other non-hemorrhagic viruses, as it seem to depend on the nanosilver binding to these hemorrhagic viruses in order to be carried into the cell, where the anti-replication activity occurs.
